Local Drug Delivery Strategies for Glioblastoma Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gi Doo Cha | - |
dc.contributor.author | Sonwoo Jung | - |
dc.contributor.author | Seung Hong Choi | - |
dc.contributor.author | Dae-Hyeong Kim | - |
dc.date.accessioned | 2023-01-26T02:49:32Z | - |
dc.date.available | 2023-01-26T02:49:32Z | - |
dc.date.created | 2022-12-20 | - |
dc.date.issued | 2022-07 | - |
dc.identifier.issn | 2288-2405 | - |
dc.identifier.uri | https://pr.ibs.re.kr/handle/8788114/12777 | - |
dc.description.abstract | Glioblastoma multiforme (GBM) is a brain tumor notorious for its malignancy. The key reason for the lim- ited efficacy of standard treatment is the high recurrence rate of GBM, even after surgical resection. Hence, intensive postsurgical chemical therapies, such as the systemic delivery of various drugs and/ or drug combinations, are typically followed after surgery. However, overcoming the blood-brain barrier by systemic administration to efficiently deliver drugs to the brain tumor remains a daunting goal. There- fore, various local drug delivery methods showing potential for improved therapeutic efficacy have been proposed. In particular, the recent application of electronic devices for the controlled delivery of che- motherapy drugs to GBM tissue has attracted attention. We herein review the recent progress of local drug delivery strategies, including electronics-assisted strategies, at the research and commercial level. We also present a brief discussion of the unsolved challenges and future research direction of localized chemotherapy methods for GBM. | - |
dc.publisher | 대한뇌종양학회 | - |
dc.title | Local Drug Delivery Strategies for Glioblastoma Treatment | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.identifier.rimsid | 79504 | - |
dc.contributor.affiliatedAuthor | Gi Doo Cha | - |
dc.contributor.affiliatedAuthor | Sonwoo Jung | - |
dc.contributor.affiliatedAuthor | Seung Hong Choi | - |
dc.contributor.affiliatedAuthor | Dae-Hyeong Kim | - |
dc.identifier.doi | 10.14791/btrt.2022.0017 | - |
dc.identifier.bibliographicCitation | Brain Tumor Research and Treatment, v.10, no.3, pp.151 - 157 | - |
dc.relation.isPartOf | Brain Tumor Research and Treatment | - |
dc.citation.title | Brain Tumor Research and Treatment | - |
dc.citation.volume | 10 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 151 | - |
dc.citation.endPage | 157 | - |
dc.identifier.kciid | SER000004156 | - |
dc.description.journalClass | 2 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Drug administration routes | - |
dc.subject.keywordAuthor | Chemotherapy | - |
dc.subject.keywordAuthor | Blood-brain barrier | - |
dc.subject.keywordAuthor | Brain tumor | - |
dc.subject.keywordAuthor | Absorbable implants | - |
dc.subject.keywordAuthor | Drug delivery systems | - |